報價延遲最少15分鐘:2025/07/19 13:18 EDT
常規時段
|
|
|
|
|
||||||||||||
|
|
|
|
|
1.32 
|
|
|
| 價值評估 |
|
盈利(現時/預測)
-2.51/-1.25
|
|
企業價值
13.50M
|
| 資產負債 |
|
每股賬面淨值
-0.42
|
| 現金流量 |
|
現金流量率
--
|
| 損益表 |
|
收益
8.51M
|
|
每股收益
0.28
|
|
同行比較
|
||||||||||||||||||||||||||||||||||||||||||||||||
|
報價延遲最少15分鐘：2025/07/19 13:18 EDT
同行比較之報價最少15分鐘延遲
|
業務概覽
|
|||
| Evogene Ltd is a computational biology company targeting to revolutionize product development for life-science based industries, including human health, agriculture, and industrial applications. The company established its technology, the Computational Predictive Biology (CPB) platform. The CPB platform is designed to computationally discover and develop life-science products based on microbes, small molecules, and genetic elements as the core components for such products. It holds several subsidiaries utilizing the CPB platform for the development of human microbiome-based therapeutics, medical cannabis, ag-biologicals, ag-chemicals, seed traits, and ag-solutions for castor oil production. It generates maximum revenue from the Agriculture segment, followed by Industry. |
